 Christian Francom
Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngoscopy | 2 | 2020 | 95 | 1.280 |
Why?
| | Bronchoscopy | 2 | 2020 | 244 | 1.200 |
Why?
| | Liposarcoma, Myxoid | 1 | 2019 | 6 | 0.680 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2019 | 11 | 0.680 |
Why?
| | Facial Neoplasms | 1 | 2019 | 18 | 0.670 |
Why?
| | Respiratory System | 2 | 2019 | 141 | 0.630 |
Why?
| | Betacoronavirus | 1 | 2020 | 255 | 0.570 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 220 | 0.560 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 346 | 0.500 |
Why?
| | Coronavirus Infections | 1 | 2020 | 339 | 0.490 |
Why?
| | Pandemics | 1 | 2020 | 1354 | 0.400 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 6 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 6 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 9 | 0.230 |
Why?
| | Child | 10 | 2023 | 18876 | 0.230 |
Why?
| | Cholesteatoma | 1 | 2023 | 11 | 0.230 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 696 | 0.220 |
Why?
| | Croup | 1 | 2023 | 22 | 0.220 |
Why?
| | Tympanoplasty | 1 | 2022 | 7 | 0.210 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 12 | 0.200 |
Why?
| | Laryngeal Diseases | 1 | 2021 | 20 | 0.190 |
Why?
| | Perioperative Period | 1 | 2020 | 48 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 264 | 0.180 |
Why?
| | Tonsillectomy | 1 | 2021 | 80 | 0.180 |
Why?
| | Abscess | 1 | 2020 | 72 | 0.180 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 133 | 0.180 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.170 |
Why?
| | Tracheostomy | 1 | 2021 | 100 | 0.170 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 132 | 0.170 |
Why?
| | Airway Obstruction | 1 | 2021 | 165 | 0.160 |
Why?
| | Clinical Protocols | 1 | 2020 | 232 | 0.160 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 141 | 0.150 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 186 | 0.150 |
Why?
| | Patient Care Team | 1 | 2019 | 520 | 0.120 |
Why?
| | Trachea | 1 | 2016 | 221 | 0.120 |
Why?
| | Receptor, IGF Type 1 | 1 | 2012 | 59 | 0.110 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 70 | 0.110 |
Why?
| | Humans | 13 | 2023 | 117047 | 0.110 |
Why?
| | Mouth Neoplasms | 1 | 2012 | 79 | 0.100 |
Why?
| | Male | 7 | 2023 | 56660 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2818 | 0.100 |
Why?
| | Quinazolines | 1 | 2012 | 244 | 0.100 |
Why?
| | Asthma | 1 | 2023 | 2156 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2012 | 569 | 0.080 |
Why?
| | Child, Preschool | 2 | 2023 | 9322 | 0.080 |
Why?
| | Infant | 2 | 2020 | 8121 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2023 | 12823 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3121 | 0.080 |
Why?
| | Female | 7 | 2023 | 60630 | 0.080 |
Why?
| | Adolescent | 3 | 2023 | 18213 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 610 | 0.070 |
Why?
| | Prospective Studies | 1 | 2018 | 6389 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 803 | 0.070 |
Why?
| | Ear Canal | 1 | 2023 | 15 | 0.060 |
Why?
| | Ear | 1 | 2023 | 33 | 0.060 |
Why?
| | Hyperplasia | 1 | 2023 | 169 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 208 | 0.050 |
Why?
| | Cough | 1 | 2023 | 101 | 0.050 |
Why?
| | Palatine Tonsil | 1 | 2021 | 31 | 0.050 |
Why?
| | Adenoidectomy | 1 | 2021 | 63 | 0.050 |
Why?
| | Obstetric Labor Complications | 1 | 2021 | 31 | 0.050 |
Why?
| | Nasal Septum | 1 | 2020 | 17 | 0.050 |
Why?
| | Hematoma | 1 | 2020 | 50 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 508 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 423 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 2021 | 166 | 0.040 |
Why?
| | Cesarean Section | 1 | 2021 | 167 | 0.040 |
Why?
| | Swine | 1 | 2022 | 714 | 0.040 |
Why?
| | Models, Organizational | 1 | 2019 | 144 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 126 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 179 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 766 | 0.040 |
Why?
| | Program Development | 1 | 2019 | 347 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 544 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2016 | 140 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 348 | 0.030 |
Why?
| | Endoscopy | 1 | 2016 | 266 | 0.030 |
Why?
| | Sheep | 1 | 2016 | 763 | 0.030 |
Why?
| | Cyclin D | 1 | 2012 | 6 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 497 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2012 | 25 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 2012 | 80 | 0.030 |
Why?
| | S Phase | 1 | 2012 | 74 | 0.030 |
Why?
| | Cytoplasm | 1 | 2012 | 269 | 0.030 |
Why?
| | Adult | 2 | 2023 | 31003 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2012 | 291 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5170 | 0.020 |
Why?
| | Cell Cycle | 1 | 2012 | 546 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 379 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2012 | 572 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1689 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 5653 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2012 | 683 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1590 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1889 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 668 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 9256 | 0.020 |
Why?
| | Animals | 2 | 2022 | 32736 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 10674 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 2813 | 0.020 |
Why?
|
|
Francom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|